Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 11/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 11/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 8/20 | 0.40 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.40 |
| ▸ | OPRL1 | P41146 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 4/20 | 0.35 |
| ▸ | MAOA | P21397 | 2/20 | 0.35 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8353193 | 0.93 | SLC6A4 (0.45) | SLC6A4SLC6A3SLC6A2OPRM1OPRL1 | |
| SCHEMBL8350793 | 0.93 | SLC6A4 (0.49) | SLC6A4SLC6A3SLC6A2 | |
| SCHEMBL8353028 | 0.84 | LMNA (0.38) | SLC6A4SLC6A3SLC6A2OPRM1OPRL1 | |
| SCHEMBL8353216 | 0.81 | SLC6A4 (0.58) | SLC6A4SLC6A3SLC6A2OPRM1OPRL1 | |
| SCHEMBL8353944 | 0.77 | SLC6A4 (0.42) | SLC6A4SLC6A3SLC6A2LMNA | |
| SCHEMBL8353218 | 0.76 | SLC6A4 (0.53) | SLC6A4SLC6A3SLC6A2OPRM1OPRL1 | |
| SCHEMBL14347736 | 0.76 | DUT (0.39) | SLC6A4SLC6A3SLC6A2OPRM1OPRL1 | |
| SCHEMBL8353489 | 0.76 | CYP3A4 (0.39) | SLC6A4SLC6A3SLC6A2OPRM1OPRL1 | |
| SCHEMBL8354121 | 0.74 | SLC6A4 (0.64) | SLC6A4SLC6A3SLC6A2OPRM1OPRL1 | |
| SCHEMBL14347765 | 0.74 | SLC6A4 (0.69) | SLC6A4SLC6A3SLC6A2OPRM1OPRL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7312214-B2 | 1, 1-disubstituted cycloalkyl derivatives as factor Xa inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2007-12-25 | — | — | US | disclosed |
| WO-2003099276-A1 | 1,1-DISUBSTITUTED CYCLOALKYL DERIVATIVES AS FACTOR XA INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2003-12-04 | — | — | WO | disclosed |